Autres langues Biomark Diagnostics Inc.

Actions

20B

CA09073K1084

Marché Fermé - Deutsche Boerse AG Autres places de cotation 08:16:17 06/05/2024			Varia. 5j.	Varia. 1 janv.
0,166 ^EUR	-0,60%		-8,29%	+12,93%

29/02	Biomark Diagnostics Inc. publie ses résultats pour le troisième trimestre et les neuf mois clos le 31 décembre 2023	CI
28/02	BioMark Diagnostics Inc. s'associe à Rubix LS pour faire progresser le dépistage sanguin du cancer dans les communautés mal desservies	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Biomark Diagnostics : Announces Warrant Extension and Granting of Options	06/05
BioMark Announces Warrant Extension and Granting of Options	18/04
BioMark to Advance Development of Cancer Treatment for Glioblastoma	09/04
Biomark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	29/02
BioMark Diagnostics Inc. Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities	28/02
BioMark Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities	28/02
Biomark Diagnostics Inc. Appoints Theresa Peterson as Member of Advisory Team	26/02
Theresa Peterson Joins Biomark's Advisory Team	26/02
Biomark Diagnostics Closes $1.9 Million Non-Brokered Private Placement	29/12
BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement	29/12
Biomark Diagnostics Inc. announced that it has received CAD 1.9 million in funding	29/12
BioMark Announces New Patent Granted in Canada For Liquid Biopsy Based Legacy Assay	04/12
BioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay	04/12
BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Term	28/11
Biomark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	28/11
BioMark Diagnostics Inc. Appoints Randolph Ford to its Strategic Advisory Team	14/11
BioMark Strengthens and Expands Its Strategic Advisory Team in Pursuit of Commercialization Initiatives	14/11
BioMark Announces Financial Contribution from the City of Quebec to Support Commercialization Initiatives of Its Proprietary Lung Cancer Detection Test	07/11
BioMark to Unveil Results of Its Early Breast Cancer Study at the Upcoming San Antonio Breast Cancer Symposium	24/10/23
Biomark Diagnostics : Une Technologie d’ici Pour Mieux Diagnostiquer le Cancer du Poumon – Local Technology for Improved Lung Cancer Diagnosis	10/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Biomark Diagnostics Inc.

Actions

20B

CA09073K1084

Autres langues

Filtres